Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Medical Adrenalectomy for D0.5 Prostate Cancer
NCT00006371Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- May 2000
- Primary completion
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in prostate cancer (PCa) comparing Hydrocortisone + Ketoconazole with Hydrocortisone + Aminoglutethimide (2 arms). Primary endpoints: Prostate-Specific Antigen Response Proportion at 1 year and Duration of Response. Started May 2000; status: terminated.
02
Drugs
ketoconazoleaminoglutethimide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00006371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006371.